Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Spitali, P.

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(1 - 24 of 59)

Pages

Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers
Spatial transcriptomics reveal markers of histopathological changes in Duchenne muscular dystrophy mouse models
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers
Diffusion-tensor magnetic resonance imaging captures increased skeletal muscle fibre diameters in Becker muscular dystrophy
Multiomic characterization of disease progression in mice lacking dystrophin
Multiomic characterization of disease progression in mice lacking dystrophin
Longitudinal Assessment of creatine kinase, creatine/creatinine(ratio), and myostatin as monitoring biomarkers in Becker muscular dystrophy
Longitudinal assessment of creatine kinase, creatine/creatinineratio, and myostatin as monitoring biomarkers in Becker muscular dystrophy
Longitudinal assessment of creatine kinase, creatine/creatinine ratio, and myostatin as monitoring biomarkers in Becker muscular dystrophy
Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice
Longitudinal assessment of creatine kinase, creatine/creatinine ratio and myostatin as monitoring biomarkers in Becker muscular dystrophy
Value of global longitudinal strain for identification and monitoring of left ventricular dysfunction in Becker muscular dystrophy
The neurocognitive profile of adults with Becker muscular dystrophy in the Netherlands
Penalized regression calibration
Penalized regression calibration
Penalized regression calibration
Negative Binomial mixed models estimated with the maximum likelihood method can be used for longitudinal RNAseq data
Plasma lipidomic analysis shows a disease progression signature in mdx mice
Corrigendum to: Poisson-Tweedie mixed-effects model
Pathway testing for longitudinal metabolomics
Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients
Evaluation of blood gene expression levels in facioscapulohumeral muscular dystrophy patients
Rimeporide as a first- in-class NHE-1 inhibitor

Pages